Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Beta interferon therapy in hairy cell leukemia].

P von Wussow, J Dühlmann, T Grethlein

    Klinische Wochenschrift
    |July 15, 1987
    PubMed
    Summary

    Natural beta-interferon (beta-IFN) showed some clinical efficacy in treating hairy-cell leukemia patients. While side effects were noted, partial and minor responses were observed in evaluable participants.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Functional properties of human platelets derived in vitro from CD34<sup>+</sup> cells.

    Scientific reports·2020
    Same author

    Microtubule plus-end tracking Adenopolyposis Coli negatively regulates proplatelet formation.

    Scientific reports·2018
    Same author

    Chronic Lymphocytic Leukemia (B-CLL) and Immunocytoma (LP-IC): Clinical and Prognostic Relevance of this Distinction.

    Leukemia & lymphoma·2016
    Same author

    Lentiviral gene rescue of a Bernard-Soulier mouse model to study platelet glycoprotein Ibβ function.

    Journal of thrombosis and haemostasis : JTH·2016
    Same author

    Intractable Posterior Epistaxis due to a Spontaneous Low-Flow Carotid-Cavernous Sinus Fistula: A Case Report and a Review of the Literature.

    Case reports in otolaryngology·2016
    Same author

    Characterization of the symbiont Rickettsia in the mirid bug Nesidiocoris tenuis (Reuter) (Heteroptera: Miridae).

    Bulletin of entomological research·2014

    Area of Science:

    • Hematology
    • Immunology
    • Oncology

    Background:

    • Hairy-cell leukemia (HCL) is a rare B-cell chronic lymphoid leukemia.
    • Treatment options for HCL have evolved, necessitating exploration of novel therapeutic agents.

    Purpose of the Study:

    • To evaluate the clinical efficacy and safety of natural beta-interferon (beta-IFN) in patients with histologically proven hairy-cell leukemia.

    Main Methods:

    • Eleven HCL patients received intravenous beta-IFN (3 x 4 million units weekly) for 2 to 6 months.
    • Treatment response was assessed based on clinical improvement and bone marrow infiltration reduction.

    Main Results:

    • Eight patients were evaluable for response.
    • Three patients achieved a partial response, and two experienced a minor response.

    Related Experiment Videos

  • One patient showed a reduction in bone marrow hairy-cell infiltration; three patients had no improvement.
  • Common side effects included flu-like symptoms, typical of interferon therapy.

    • Conclusions:

    • Natural beta-interferon (beta-IFN) demonstrates some clinical efficacy in managing hairy-cell leukemia.
    • Further research may be warranted to optimize beta-IFN treatment protocols for HCL.